81 followers
Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression. https://t.co/YCHTXUDDhy
Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression. https://t.co/YCHTXUDDhy
Spotlight: (Original article appears in Cancer Immunology, Immunotherapy https://t.co/JCHFZMAanv) https://t.co/TDpxvZi47u